RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kissei Pharmaceutical Co Stock

Kissei Pharmaceutical Co Net Income 2024

Kissei Pharmaceutical Co Net Income

11.16 B JPY

Ticker

4547.T

ISIN

JP3240600001

WKN

881370

In 2024, Kissei Pharmaceutical Co's profit amounted to 11.16 B JPY, a 6% increase from the 10.53 B JPY profit recorded in the previous year.

The Kissei Pharmaceutical Co Net Income history

YEARNET INCOME (undefined JPY)
2027e7.87
2026e9.52
2025e11.8
202411.16
202310.53
202212.92
20215.29
20202.82
20195.48
20189.05
20177.73
20168.17
20157.17
20149.09
20135.02
20124.77
20114
20104.37
20092.06
20082.33
20071.57
20062.03
20054.7

Kissei Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kissei Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kissei Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kissei Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kissei Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kissei Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kissei Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kissei Pharmaceutical Co’s growth potential.

Kissei Pharmaceutical Co Revenue, EBIT and net profit per share

DateKissei Pharmaceutical Co RevenueKissei Pharmaceutical Co EBITKissei Pharmaceutical Co Net Income
2027e90.2 B undefined0 undefined7.87 B undefined
2026e86.61 B undefined7.47 T undefined9.52 B undefined
2025e84.98 B undefined6.87 T undefined11.8 B undefined
202475.58 B undefined4.02 B undefined11.16 B undefined
202367.49 B undefined-1.13 B undefined10.53 B undefined
202265.38 B undefined-1.4 B undefined12.92 B undefined
202169.04 B undefined1.51 B undefined5.29 B undefined
202063.23 B undefined1.86 B undefined2.82 B undefined
201972.3 B undefined6.2 B undefined5.48 B undefined
201874.01 B undefined9.89 B undefined9.05 B undefined
201771.71 B undefined8.49 B undefined7.73 B undefined
201671.29 B undefined10.27 B undefined8.17 B undefined
201570.11 B undefined8.33 B undefined7.17 B undefined
201470.4 B undefined12.3 B undefined9.09 B undefined
201362.49 B undefined7.76 B undefined5.02 B undefined
201264.62 B undefined7.47 B undefined4.77 B undefined
201164.39 B undefined6.46 B undefined4 B undefined
201062.18 B undefined6.59 B undefined4.37 B undefined
200964.54 B undefined6.38 B undefined2.06 B undefined
200861.48 B undefined4.27 B undefined2.33 B undefined
200764.22 B undefined2.59 B undefined1.57 B undefined
200664.01 B undefined1.88 B undefined2.03 B undefined
200560.93 B undefined5.52 B undefined4.7 B undefined

Kissei Pharmaceutical Co stock margins

The Kissei Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kissei Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kissei Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kissei Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Kissei Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kissei Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kissei Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kissei Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kissei Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kissei Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kissei Pharmaceutical Co Margin History

Kissei Pharmaceutical Co Gross marginKissei Pharmaceutical Co Profit marginKissei Pharmaceutical Co EBIT marginKissei Pharmaceutical Co Profit margin
2027e49.41 %0 %8.73 %
2026e49.41 %8,629.09 %10.99 %
2025e49.41 %8,082.38 %13.89 %
202449.41 %5.31 %14.77 %
202347.97 %-1.67 %15.6 %
202247.78 %-2.14 %19.76 %
202147.39 %2.18 %7.65 %
202055.18 %2.94 %4.45 %
201963.02 %8.58 %7.58 %
201865.03 %13.36 %12.22 %
201765.03 %11.84 %10.77 %
201666.92 %14.41 %11.45 %
201565.68 %11.89 %10.22 %
201467.07 %17.47 %12.92 %
201366.16 %12.42 %8.03 %
201264.56 %11.55 %7.38 %
201165.07 %10.04 %6.22 %
201065.07 %10.59 %7.03 %
200963.22 %9.89 %3.19 %
200862.92 %6.94 %3.78 %
200756.29 %4.04 %2.44 %
200655.8 %2.93 %3.17 %
200561.38 %9.06 %7.71 %

Kissei Pharmaceutical Co Aktienanalyse

What does Kissei Pharmaceutical Co do?

Kissei Pharmaceutical Co., Ltd. is a leading innovative company in Japan that focuses on the development and production of pharmaceuticals for various diseases. The Kissei Group consists of several companies that work together in the development and production of pharmaceuticals and other medical products. History: Kissei Pharmaceutical was founded in 1946 in Matsumoto, Japan. The company initially manufactured drugs for skin and respiratory diseases and later expanded its portfolio to include drugs for cancer and Parkinson's. Over time, Kissei Pharmaceutical has also invested in research and development and has become a key player in the global pharmaceutical industry. Business model: Kissei Pharmaceutical's business model is based on the development and marketing of innovative drugs for various diseases. The company's strategy is to focus on niche markets and invest in research and development to develop groundbreaking drugs. The company also seeks partnerships and has a strong presence in the Asian market. Divisions: Kissei Pharmaceutical is divided into various business areas, including cancer, neurological disorders, metabolic disorders, and dermatological diseases. The largest business area is oncology, where the company offers many products for the treatment of cancer. The neurology division includes products for the treatment of Parkinson's and Alzheimer's. In the field of metabolic disorders, Kissei Pharmaceutical offers drugs for the treatment of diabetes and obesity. In dermatology, the products include skincare products for various skin conditions such as eczema and psoriasis. Products: Kissei Pharmaceutical offers a wide range of pharmaceutical products for a variety of diseases. In the field of oncology, the company produces drugs such as docetaxel for breast and lung cancer, and irinotecan for colon cancer. In the field of neurological disorders, Kissei Pharmaceutical produces drugs such as levodopa for Parkinson's, and TAK-659 for cancer patients with high blood sugar levels. In the field of metabolic disorders, the company produces drugs such as insulin for the treatment of diabetes, and leptin for the treatment of obesity. In dermatology, Kissei Pharmaceutical produces drugs such as epicederm for eczema and psoriasis, and apimo for acne. Conclusion: Kissei Pharmaceutical is an innovative company in Japan that specializes in the development and production of pharmaceuticals for various diseases. The company has a strong presence in the Asian market and works closely with partners to develop new drugs. With its various business divisions and wide range of products, Kissei Pharmaceutical is a key player in the global pharmaceutical industry. Kissei Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Kissei Pharmaceutical Co's Profit Margins

The profit margins of Kissei Pharmaceutical Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Kissei Pharmaceutical Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Kissei Pharmaceutical Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Kissei Pharmaceutical Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Kissei Pharmaceutical Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Kissei Pharmaceutical Co stock

How much profit has Kissei Pharmaceutical Co made this year?

Kissei Pharmaceutical Co has made 11.16 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by 6% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Kissei Pharmaceutical Co publish its earnings?

Kissei Pharmaceutical Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Kissei Pharmaceutical Co?

The profits of Kissei Pharmaceutical Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Kissei Pharmaceutical Co?

You can learn more about the earnings of Kissei Pharmaceutical Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Kissei Pharmaceutical Co pay?

Over the past 12 months, Kissei Pharmaceutical Co paid a dividend of 86 JPY . This corresponds to a dividend yield of about 2.31 %. For the coming 12 months, Kissei Pharmaceutical Co is expected to pay a dividend of 89.31 JPY.

What is the dividend yield of Kissei Pharmaceutical Co?

The current dividend yield of Kissei Pharmaceutical Co is 2.31 %.

When does Kissei Pharmaceutical Co pay dividends?

Kissei Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kissei Pharmaceutical Co?

Kissei Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kissei Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 89.31 JPY are expected. This corresponds to a dividend yield of 2.4 %.

In which sector is Kissei Pharmaceutical Co located?

Kissei Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kissei Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kissei Pharmaceutical Co from 12/1/2024 amounting to 45 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kissei Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kissei Pharmaceutical Co in the year 2023?

In the year 2023, Kissei Pharmaceutical Co distributed 81 JPY as dividends.

In which currency does Kissei Pharmaceutical Co pay out the dividend?

The dividends of Kissei Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kissei Pharmaceutical Co

Our stock analysis for Kissei Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kissei Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.